Embolx's Unattributed Round

Embolx raised a round of funding on March 10, 2014.

Embolx develops unique delivery systems for "superselective" (highly targeted) tumor embolization that enable oncologists & radiologists to deliver precise doses of drug directly into the tumor vascul…

Articles about Embolx's Unattributed Round: